Sweta Kochhar

Learn More
The aim of this study was to describe the presenting features and outcomes of consecutive patients with liver injury attributed to interferon beta. The presenting features of eight subjects with clinically apparent liver injury attributed to interferon beta enrolled in the U.S. Drug-Induced Liver Injury Network (DILIN) prospective registry between 2004 and(More)
  • 1